Hylla
Titel och upphov Drug treatment expenditure : a methodological overveiw
Utgivning, distribution etc. Publications Office of the European Union, Luxembourg : 2017
Fysisk beskrivning
Serietitel - ej biuppslagsform EMCDDA insights series, ISSN 1606-1683 ; 24
Anmärkning: Innehållsbeskrivning, sammanfattning Each year, around 1.2 million people in the European Union (EU) undergo treatment for problems related to drug abuse. There are associated requirements for policymakers and planners to determine the capacity and performance of national treatment systems and evaluate their costs. Responses are required to central policy questions such as What treatments are offered?, Are they effective? and How much does treatment cost?. However, despite the collection of data on treatment activity being relatively well established in Europe, there has been limited focus on the costs of, and expenditure on, drug treatment. Limited data and/or insufficient insight into the financing of drug treatment will inevitably hinder the efficient allocation of resources. This European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Insights report gathers together studies from a wide range of experts, providing a unique overview of the methodologies currently used for estimating drug treatment expenditure. In the absence of a systematic discussion of these issues, there has been little opportunity for policymakers, practitioners and researchers to take advantage of existing knowledge and experience. With the goal of taking the first step towards closing this gap, this report brings together a set of diverse studies encompassing much of the recent work on drug treatment expenditure in different parts of the world. It therefore reflects the current state of the art in this field and, by focusing on methods, it will facilitate analysis of the main methodological commonalities and considerations arising from these estimates. (From the abstract)
Term
Indexterm - Okontrollerad
Institutionsnamn Europeiska centrumet för kontroll av narkotika och narkotikamissbruk Utgivare
*00002917nam 122002657a 4500
*00129042
*00520171113143213.0
*008171113s2017 lu a|||e |000 0 eng c
*020 $z978-294972132
*0248 $aTD-XD-17-001-EN-C
*035 $a(SE-LIBR)21916337
*24510$aDrug treatment expenditure :$ba methodological overveiw
*260 $aLuxembourg :$bPublications Office of the European Union,$c2017
*300 $a191 s. :$bill.
*4900 $aEMCDDA insights series,$x1606-1683 ;$v24
*5203 $aEach year, around 1.2 million people in the European Union (EU) undergo treatment for problems related to drug abuse. There are associated requirements for policymakers and planners to determine the capacity and performance of national treatment systems and evaluate their costs. Responses are required to central policy questions such as What treatments are offered?, Are they effective? and How much does treatment cost?. However, despite the collection of data on treatment activity being relatively well established in Europe, there has been limited focus on the costs of, and expenditure on, drug treatment. Limited data and/or insufficient insight into the financing of drug treatment will inevitably hinder the efficient allocation of resources. This European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Insights report gathers together studies from a wide range of experts, providing a unique overview of the methodologies currently used for estimating drug treatment expenditure. In the absence of a systematic discussion of these issues, there has been little opportunity for policymakers, practitioners and researchers to take advantage of existing knowledge and experience. With the goal of taking the first step towards closing this gap, this report brings together a set of diverse studies encompassing much of the recent work on drug treatment expenditure in different parts of the world. It therefore reflects the current state of the art in this field and, by focusing on methods, it will facilitate analysis of the main methodological commonalities and considerations arising from these estimates. (From the abstract)
*650 4$aCost-benefit analysis
*650 4$aCost control
*650 4$aTherapeutics
*650 4$aHealth expenditures
*650 4$aEconomics, medical
*650 4$aSubstance-related disorders
*650 4$aAustralia
*650 4$aCroatia
*650 4$aCzech Republic
*650 4$aHungary
*650 4$aGreat Britain
*650 4$aItaly
*650 4$aPortugal
*650 4$aUnited States
*650 4$aFrance
*653 $aKostnader
*653 $aHälsoekonomi
*653 $aBehandling
*653 $aNarkotikamissbruk
*7102 $aEuropeiska centrumet för kontroll av narkotika och narkotikamissbruk$4pbl$0114488
*852 $h15c20
*85641$uhttp://dx.publications.europa.eu/10.2810/812985
^
Det finns inga omdömen till denna titeln.
Klicka här
för att vara den första som skriver ett omdöme.